HormonesInjectable hyaluronic acid shows early promise for menopause vaginal symptoms, but evidence remains thin
Genitourinary syndrome of menopause (GSM) is a chronic condition caused by falling estrogen. It brings vaginal dryness, painful sex and urinary symptoms. Local estrogen works well, but many women cannot or prefer not to use hormones. This narrative review looks at non-hormonal local options, focusing on injectable hyaluronic acid, a molecule that helps tissue hold water and keeps the extracellular matrix flexible. Injections aim to deliver it into deeper tissue layers than topical products reach. One formulation, hybrid cooperative complex hyaluronic acid (HCC-HA), has been tested in small prospective studies and one randomized trial, in women with sexual dysfunction rather than strictly defined GSM. Some symptoms, including dryness and painful sex, may improve, but not all sexual-function and quality-of-life measures did. No serious adverse events were reported. The authors conclude the evidence does not yet support routine or guideline use. Note that one author works for the manufacturer's affiliated company, and larger independent trials are needed.